STAT News · Scour

Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting

statnews.com·6d

Why we left the FDA: Six former officials share their stories

statnews.com·6d

Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers

statnews.com·6d

Key takeaways from WHO briefing on hantavirus cruise ship outbreak

statnews.com·6d

Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

statnews.com·1w

Science is becoming less disruptive. Is an aging workforce to blame?

statnews.com·1w

Official leading CDC’s cruise ship program retires

statnews.com·1w

STAT+: More political interference at the FDA?

statnews.com·1w

STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more

statnews.com·1w

STAT+: FDA to reconsider treatment for rare cancer after surprise rejection

statnews.com·1w

STAT+: OpenAI’s health policy wishlist, CGM news from Dexcom, and more

statnews.com·1w

STAT+: FDA to reconsider treatment for rare cancer after its surprise rejection

statnews.com·1w

Hospital shootings steadily increased since 2000

statnews.com·1w

STAT+: Next-gen Duchenne drug from Entrada disappoints

statnews.com·1w

STAT+: Color me skeptical: Drinking gold is not an ALS cure

statnews.com·1w

STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B

statnews.com·1w

Opinion: Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came true

statnews.com·1w

Public health experts are worried about the cruise ship hantavirus outbreak, but not for the reason you might think

statnews.com·1w

STAT+: What was lost at the FDA

statnews.com·1w

STAT+: Oregon hospitals won’t outsource to national physician chain after all

statnews.com·1w

Log in to enable infinite scrolling